These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
381 related items for PubMed ID: 1715961
1. OCI/AML-4 an acute myeloblastic leukemia cell line: regulation and response to cytosine arabinoside. Koistinen P, Wang C, Yang GS, Wang YF, Williams DE, Lyman SD, Minden MD, McCulloch EA. Leukemia; 1991 Aug; 5(8):704-11. PubMed ID: 1715961 [Abstract] [Full Text] [Related]
2. Granulocyte-macrophage colony-stimulating factor and interleukin-3 protect leukemic blast cells from ara-C toxicity. Koistinen P, Wang C, Curtis JE, McCulloch EA. Leukemia; 1991 Sep; 5(9):789-95. PubMed ID: 1719308 [Abstract] [Full Text] [Related]
4. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines. Budel LM, Delwel R, van Buitenen C, Hoogerbrugge H, Löwenberg B. Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401 [Abstract] [Full Text] [Related]
5. Influence of schedule on regulated sensitivity of AML blasts to cytosine arabinoside. Yang GS, Minden MD, McCulloch EA. Leukemia; 1993 Jul; 7(7):1012-9. PubMed ID: 7686602 [Abstract] [Full Text] [Related]
7. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation. te Boekhorst PA, Löwenberg B, Vlastuin M, Sonneveld P. Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839 [Abstract] [Full Text] [Related]
8. Mast cell growth factor, a ligand for the receptor encoded by c-kit, affects the growth in culture of the blast cells of acute myeloblastic leukemia. Wang C, Koistinen P, Yang GS, Williams DE, Lyman SD, Minden MD, McCulloch EA. Leukemia; 1991 Jun; 5(6):493-9. PubMed ID: 1711640 [Abstract] [Full Text] [Related]
9. Hematopoietic growth factor stimulation and cytarabine cytotoxicity in vitro: effects in untreated and relapsed or primary refractory acute myeloid leukemia cells. te Boekhorst PA, Löwenberg B, Sonneveld P. Leukemia; 1994 Sep; 8(9):1480-6. PubMed ID: 7522289 [Abstract] [Full Text] [Related]
10. Mechanism of cytosine arabinoside toxicity to the blast cells of acute myeloblastic leukemia: involvement of free radicals. Hu ZB, Yang GS, Li M, Miyamoto N, Minden MD, McCulloch EA. Leukemia; 1995 May; 9(5):789-98. PubMed ID: 7769841 [Abstract] [Full Text] [Related]
11. Regulation by retinoic acid and hydrocortisone of the anthracycline sensitivity of blast cells of acute myeloblastic leukemia. Yang GS, Minden MD, McCulloch EA. Leukemia; 1994 Dec; 8(12):2065-75. PubMed ID: 7807996 [Abstract] [Full Text] [Related]
12. Combination of hematopoietic growth factors containing IL-3 induce acute myeloid leukemia cell sensitization to cycle specific and cycle non-specific drugs. Tafuri A, Lemoli RM, Chen R, Gulati SC, Clarkson BD, Andreeff M. Leukemia; 1994 May; 8(5):749-57. PubMed ID: 7514244 [Abstract] [Full Text] [Related]
14. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination. Lemoli RM, Gulati SC, Strife A, Lambek C, Perez A, Clarkson BD. Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711 [Abstract] [Full Text] [Related]
15. Fluorescence-labeling of nicks in DNA from leukemic blast cells as a measure of damage following cytosine arabinoside. Application to the study of regulated drug sensitivity. Yang GS, Wang C, Minden MD, McCulloch EA. Leukemia; 1994 Dec; 8(12):2052-9. PubMed ID: 7807994 [Abstract] [Full Text] [Related]
17. Effects of rGM-CSF and rG-CSF on the cisplatin sensitivity of the blast cells of acute myeloblastic leukemia. Wang YF, Kelleher CA, Minkin S, McCulloch EA. Leukemia; 1991 Mar; 5(3):239-48. PubMed ID: 1707468 [Abstract] [Full Text] [Related]
19. [Enhanced sensitivity to cytosine arabinoside by combined stimulation of steel factor and GM-CSF in a factor-dependent leukemic cell line, MO7e--in terms of a possible clinical application to AML treatment]. Gotoh A, Kawanishi Y, Kurosawa K, Miyazawa K, Ohtaka M, Aizawa S, Kimura Y, Yoshikawa O, Toyama K. Rinsho Ketsueki; 1993 Jul; 34(7):821-8. PubMed ID: 7689660 [Abstract] [Full Text] [Related]